Jupiter Life Line Hospitals (NSE:JLHL) Beneish M-Score: -2.18 (As of Jul. 03, 2026)


NSE:JLHL Jupiter Life Line Hospitals Ltd NSE:JLHL
69 GF Score
Price ₹1,456.30
GF Value ₹1,787.54
Valuation Modestly Undervalued
View Full Analysis

What is Jupiter Life Line Hospitals Beneish M-Score?

Jupiter Life Line Hospitals NSE:JLHL +0.20% 69 Beneish M-Score is -2.18 as of Jul. 03, 2026. GuruFocus rates NSE:JLHL with a GF Score™ of 69/100 and a GF Value™ of ₹1,787.54 (Modestly Undervalued). Among 631 Healthcare Providers & Services companies, Jupiter Life Line Hospitals ranks worse than 74.8% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.18 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Jupiter Life Line Hospitals's Beneish M-Score or its related term are showing as below:

NSE:JLHL' s Beneish M-Score Range Over the Past 10 Years
Min: -3.66   Med: -1.98   Max: -1.25
Current: -2.18

During the past 6 years, the highest Beneish M-Score of Jupiter Life Line Hospitals was -1.25. The lowest was -3.66. And the median was -1.98.


Jupiter Life Line Hospitals Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Jupiter Life Line Hospitals's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jupiter Life Line Hospitals Beneish M-Score Chart

Jupiter Life Line Hospitals Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial 0.00 -1.78 -1.25 -3.66 -2.18

Jupiter Life Line Hospitals Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.66 0.00 0.00 0.00 -2.18

NSE:JLHL vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Jupiter Life Line Hospitals's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jupiter Life Line Hospitals Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jupiter Life Line Hospitals's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Jupiter Life Line Hospitals's Beneish M-Score falls into.


NSE:JLHL
69GF Score
Jupiter Life Line Hospitals Ltd NSE:JLHL
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jupiter Life Line Hospitals Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Jupiter Life Line Hospitals for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.5503+0.528 * 0.9929+0.404 * 0.7089+0.892 * 1.1515+0.115 * 0.9171
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0529+4.679 * -0.030927-0.327 * 1.1874
=-2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹820 Mil.
Revenue was ₹14,985 Mil.
Gross Profit was ₹11,816 Mil.
Total Current Assets was ₹6,849 Mil.
Total Assets was ₹23,831 Mil.
Property, Plant and Equipment(Net PPE) was ₹16,247 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹876 Mil.
Selling, General, & Admin. Expense(SGA) was ₹3,881 Mil.
Total Current Liabilities was ₹2,266 Mil.
Long-Term Debt & Capital Lease Obligation was ₹5,664 Mil.
Net Income was ₹1,940 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹2,677 Mil.
Total Receivables was ₹459 Mil.
Revenue was ₹13,013 Mil.
Gross Profit was ₹10,189 Mil.
Total Current Assets was ₹6,925 Mil.
Total Assets was ₹19,358 Mil.
Property, Plant and Equipment(Net PPE) was ₹11,590 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹571 Mil.
Selling, General, & Admin. Expense(SGA) was ₹3,201 Mil.
Total Current Liabilities was ₹1,584 Mil.
Long-Term Debt & Capital Lease Obligation was ₹3,841 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(819.98 / 14984.95) / (459.33 / 13013.2)
=0.05472 / 0.035297
=1.5503

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(10189.04 / 13013.2) / (11816.43 / 14984.95)
=0.782977 / 0.788553
=0.9929

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (6849 + 16247.22) / 23831.29) / (1 - (6925.37 + 11589.89) / 19357.5)
=0.030845 / 0.04351
=0.7089

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=14984.95 / 13013.2
=1.1515

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(570.83 / (570.83 + 11589.89)) / (876.4 / (876.4 + 16247.22))
=0.04694 / 0.051181
=0.9171

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(3881.42 / 14984.95) / (3201.34 / 13013.2)
=0.259021 / 0.246007
=1.0529

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((5664.3 + 2265.75) / 23831.29) / ((3840.86 + 1583.88) / 19357.5)
=0.332758 / 0.28024
=1.1874

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1940.06 - 0 - 2677.08) / 23831.29
=-0.030927

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Jupiter Life Line Hospitals has a M-score of -2.18 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.18 mean?
Jupiter Life Line Hospitals (NSE:JLHL) has a Beneish M-Score of -2.18 as of Jul. 03, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Jupiter Life Line Hospitals and its competitors. According to the industry distribution chart, Jupiter Life Line Hospitals ranks #472 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 74.8%.
Is Jupiter Life Line Hospitals' Beneish M-Score too high?
Jupiter Life Line Hospitals' current Beneish M-Score is -2.18. Based on the distribution chart, Jupiter Life Line Hospitals ranks #472 out of 631 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Jupiter Life Line Hospitals has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jupiter Life Line Hospitals' Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jupiter Life Line Hospitals ranks #472 out of 631 companies for Beneish M-Score. This places Jupiter Life Line Hospitals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Jupiter Life Line Hospitals and its competitors. Jupiter Life Line Hospitals's current Beneish M-Score is -2.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jupiter Life Line Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Jupiter Life Line Hospitals (NSE:JLHL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,787.54, compared to a current price of ₹1,456.30 — trading 18.5% below its estimated fair value. The current Beneish M-Score is -2.18. Jupiter Life Line Hospitals' overall GF Score™ is 69/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Jupiter Life Line Hospitals (NSE:JLHL), the current Beneish M-Score is -2.18 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jupiter Life Line Hospitals (NSE:JLHL) Overvalued in 2026?

Based on GuruFocus' analysis, Jupiter Life Line Hospitals stock appears to be undervalued. The current stock price of ₹1,456.30 is trading 18.5% below its estimated GF Value™ of ₹1,787.54. GuruFocus considers Jupiter Life Line Hospitals to be Modestly Undervalued.

Key valuation signals for NSE:JLHL:

  • Beneish M-Score: -2.18
  • GF Value™: ₹1,787.54 vs. price of ₹1,456.30 (18.5% below fair value)
  • GF Score™: 69/100

No single metric tells the full story. See the NSE:JLHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jupiter Life Line Hospitals Business Description

Other Exchanges 543980:India
Address Eastern Express Highway, Service Road, Next To Viviana Mall, Thane west, Thane, MH, IND, 400601
Jupiter Life Line Hospitals Ltd is a key multi-specialty tertiary and quaternary healthcare provider. The Company operates in one business and geographical segment that is Medical and Healthcare Services in India. The Hospital revenue comprises of fees charged for inpatient and outpatient hospital services and other hospital services. Services include charges for accommodation, operation theatre, medical professional services, equipment, radiology, laboratory, and pharmaceutical goods used for treating patients.
69GF Score

Get the complete analysis for NSE:JLHL

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,456.30
Price
₹1,787.54
GF Value